Skip to main content
2025 Neural Interfaces Meeting Main banner
Unparalleled proactive care. Optimizing the SCS experience. Website: neuro.biotronik.com

Imanuel Lerman, MD MS

Professor/CEO
UCSD/InflammaSense
La Jolla , California, United States

I lead the development of a wearable device that stratifies mental health disorder severity in clinical trials and clinics by recording neural signaling—Autonomic Neurography (ANG). The wearable is now capable of triggering our handheld ultra sensitive bioassay sensor or the (HUBS); it measures blood and or salivary microRNA (miRNA) and proteomic signatures that more granularly indicate biotype and categorical mental health disease severity. Our sensor platform seamlessly integrates with electronic medical records (EMR), enabling the identification of patient specific time series mental health vectors that predict reliable responder patients when they enroll in your trial and the effects of your treatments. By optimizing composite AI models, we extend inflammation detection capabilities across a range of diseases, including mental health disorders, infections, and sepsis. (www.inflammaSense.com)

In parallel, I serve as a Professor at the University of California, San Diego (UCSD), where my research focuses on neuroinflammatory mechanisms that contribute to pain, inflammation, and mental health disorders. (www.lerman-lab.org) I work alongside a some of the most highly skilled multidisciplinary team of life scientists, electrical and computer engineers, software engineers, machine learning and deep learning experts, data scientists, statisticians, IT specialists, and clinicians and experienced regulatory experts.

Presentation(s):